These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33364238)

  • 21. The Bcr-Abl inhibitor DCC-2036 inhibits necroptosis and ameliorates osteoarthritis by targeting RIPK1 and RIPK3 kinases.
    Piao L; Wu D; Rui C; Yang Y; Liu S; Liu J; Jin Z; Zhang H; Feng X; Bai L
    Biomed Pharmacother; 2023 May; 161():114528. PubMed ID: 36931029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.
    Lusthaus M; Mazkereth N; Donin N; Fishelson Z
    Front Immunol; 2018; 9():306. PubMed ID: 29527209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and characterization of potent RIPK3 inhibitors based on a tricyclic scaffold.
    Wu S; Yang Q; Ji Y; Tian S; Ma H; Du S; Lu H; He S; Zhang X
    Future Med Chem; 2022 Mar; 14(6):421-442. PubMed ID: 35167311
    [No Abstract]   [Full Text] [Related]  

  • 25. c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.
    Cao M; Chen F; Xie N; Cao MY; Chen P; Lou Q; Zhao Y; He C; Zhang S; Song X; Sun Y; Zhu W; Mou L; Luan S; Gao H
    Cell Death Dis; 2018 Nov; 9(12):1140. PubMed ID: 30442927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
    Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
    Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necroptosis in development and diseases.
    Shan B; Pan H; Najafov A; Yuan J
    Genes Dev; 2018 Mar; 32(5-6):327-340. PubMed ID: 29593066
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Dai X; Ma R; Jiang W; Deng Z; Chen L; Liang Y; Shao L; Zhao W
    Microbiol Spectr; 2022 Aug; 10(4):e0104522. PubMed ID: 35708336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases.
    Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z
    Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription modulation by CDK9 regulates inflammatory genes and RIPK3-MLKL-mediated necroptosis in periodontitis progression.
    Li J; Shi J; Pan Y; Zhao Y; Yan F; Li H; Lei L
    Sci Rep; 2019 Nov; 9(1):17369. PubMed ID: 31758083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Necroptosis: Fifty shades of RIPKs.
    Ichim G; Tait SW
    Mol Cell Oncol; 2015; 2(2):e965638. PubMed ID: 27308415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-Bound Polysaccharides from
    Pawlikowska M; Jędrzejewski T; Brożyna AA; Wrotek S
    Cell Physiol Biochem; 2020 Jun; 54(4):591-604. PubMed ID: 32531147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury.
    Martens S; Jeong M; Tonnus W; Feldmann F; Hofmans S; Goossens V; Takahashi N; Bräsen JH; Lee EW; Van der Veken P; Joossens J; Augustyns K; Fulda S; Linkermann A; Song J; Vandenabeele P
    Cell Death Dis; 2017 Jun; 8(6):e2904. PubMed ID: 28661484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Necroptosis: A Novel Pathway in Neuroinflammation.
    Yu Z; Jiang N; Su W; Zhuo Y
    Front Pharmacol; 2021; 12():701564. PubMed ID: 34322024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke via Inhibition of RIPK1-Mediated RIPK3/MLKL Signaling.
    Deng XX; Li SS; Sun FY
    Aging Dis; 2019 Aug; 10(4):807-817. PubMed ID: 31440386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation and execution mechanisms of necroptosis: an overview.
    Grootjans S; Vanden Berghe T; Vandenabeele P
    Cell Death Differ; 2017 Jul; 24(7):1184-1195. PubMed ID: 28498367
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Zhang H; Xu L; Qin X; Chen X; Cong H; Hu L; Chen L; Miao Z; Zhang W; Cai Z; Zhuang C
    J Med Chem; 2019 Jul; 62(14):6665-6681. PubMed ID: 31095385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necroptosis: a crucial pathogenic mediator of human disease.
    Choi ME; Price DR; Ryter SW; Choi AMK
    JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis.
    Dara L; Johnson H; Suda J; Win S; Gaarde W; Han D; Kaplowitz N
    Hepatology; 2015 Dec; 62(6):1847-57. PubMed ID: 26077809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibition.
    Brito H; Marques V; Afonso MB; Brown DG; Börjesson U; Selmi N; Smith DM; Roberts IO; Fitzek M; Aniceto N; Guedes RC; Moreira R; Rodrigues CMP
    Cell Death Discov; 2020; 6():6. PubMed ID: 32123582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.